Talking points for physicians, patients and caregivers considering Aduhelm ® infusion and the accelerated pathway for its approval by the FDA

Source: Molecular Neurodegeneration - Category: Neurology Authors: Tags: Commentary Source Type: research
More News: Brain | Neurology